Latest filing published 04 Nov 2025 for Dr. Lal Path Labs Ltd., €513. Read the official filing
Across 21 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Shankha Banerjee, listed as chief executive, appears in our data through filings on Dr. Lal Path Labs Ltd. shares, published by SEBI (PIT + SAST). Between 17 June 2021 and 4 November 2025, the trades on record add up to 36 filings.
On the market, this insider has only sold: 12 sales, €776k in total. Other entries cover 24 share grants. So far in 2025, the count stands at no purchases and 1 sale.
The latest filing, published on 4 November 2025, reports a share grant of €513 in Dr. Lal Path Labs Ltd. The median gap between a trade and its publication by SEBI (PIT + SAST) is 1 day. That lag is the time during which only the insider knows about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 36 declarations